BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33231709)

  • 1. Clinical significance of glycated hemoglobin in acute coronary syndrome patients from the CCC-ACS project : Findings from a multicenter retrospective observational study.
    Zhao X; Kang Y; Wang X; Yang X; Ai G; Liu Y; Xu P; Zhang J; Gu C; Zhang Y; Hao Y; Zhao D; Han Y;
    Herz; 2021 Sep; 46(Suppl 2):287-294. PubMed ID: 33231709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission fasting plasma glucose is associated with in-hospital outcomes in patients with acute coronary syndrome and diabetes: findings from the improving Care for Cardiovascular Disease in China - Acute Coronary Syndrome (CCC-ACS) project.
    Ye N; Yang L; Wang G; Bian W; Xu F; Ma C; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2020 Aug; 20(1):380. PubMed ID: 32819275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.
    Liu XJ; Wan ZF; Zhao N; Zhang YP; Mi L; Wang XH; Zhou D; Wu Y; Yuan ZY
    Cardiovasc Diabetol; 2015 Aug; 14():110. PubMed ID: 26285575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Level of HbA1c Evaluates the Extent of Coronary Atherosclerosis Lesions and the Prognosis in Diabetes with Acute Coronary Syndrome.
    Xu S; Zhou B; Zhou B; Zheng J; Xu Q; Wang B; Fu M; Meng Y
    Comput Math Methods Med; 2022; 2022():7796809. PubMed ID: 35912151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.
    Yang L; Ye N; Wang G; Bian W; Xu F; Zhao D; Liu J; Hao Y; Liu J; Yang N; Cheng H;
    BMC Cardiovasc Disord; 2021 Jul; 21(1):345. PubMed ID: 34273963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome.
    Lao Y; Feng L; Yuan Y; Zhang J; Huang X; Li M; Wu Z
    Med Sci Monit; 2018 Dec; 24():9399-9405. PubMed ID: 30587845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of glycosylated hemoglobin A1c and apolipoprotein A-1 ratio on predicting outcome of patients with acute coronary syndrome].
    Wang YJ; Mu HN; Yang RY; Zhang WD; Wang XY; Wang SM; Ji FS; Dong J; Yu X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jan; 51(1):38-44. PubMed ID: 36655240
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein A-l ratio in predicting cardiovascular outcomes in acute coronary syndrome.
    Song F; Zhou Y; Zhang K; Liang YF; He X; Li L
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):570-578. PubMed ID: 33358616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project.
    Zhou M; Liu J; Hao Y; Liu J; Huo Y; Smith SC; Ge J; Ma C; Han Y; Fonarow GC; Taubert KA; Morgan L; Yang N; Xing Y; Zhao D;
    Cardiovasc Diabetol; 2018 Nov; 17(1):147. PubMed ID: 30482187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and baseline glucose are associated with inflammation, left ventricular function and short- and long-term outcome in acute coronary syndromes: role of the novel biomarker Cyr 61.
    Winzap P; Davies A; Klingenberg R; Obeid S; Roffi M; Mach F; Räber L; Windecker S; Templin C; Nietlispach F; Nanchen D; Gencer B; Muller O; Matter CM; von Eckardstein A; Lüscher TF
    Cardiovasc Diabetol; 2019 Oct; 18(1):142. PubMed ID: 31672144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of the glycated hemoglobin levels and prognostic nutritional index as a prognostic marker in patients with acute coronary syndrome and type 2 diabetes mellitus.
    Sun S; Wang Y; Pang S; Wu X
    Lipids Health Dis; 2024 Jan; 23(1):12. PubMed ID: 38212760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes mellitus and hemoglobin A1c level on outcomes among Chinese patients with acute coronary syndrome.
    Xiong R; He L; Du X; Dong JZ; Ma CS
    Clin Cardiol; 2020 Jul; 43(7):723-731. PubMed ID: 32427378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study.
    Yang T; Fu P; Chen J; Fu X; Xu C; Liu X; Niu T
    Curr Med Res Opin; 2021 Sep; 37(9):1517-1528. PubMed ID: 34166166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
    Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
    Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
    Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
    Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A risk score to predict in-hospital mortality in patients with acute coronary syndrome at early medical contact: results from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project.
    Ran P; Yang JQ; Li J; Li G; Wang Y; Qiu J; Zhong Q; Wang Y; Wei XB; Huang JL; Siu CW; Zhou YL; Zhao D; Yu DQ; Chen JY
    Ann Transl Med; 2021 Jan; 9(2):167. PubMed ID: 33569469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.